UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

European journal of cancer (1990), 2016-02, Vol.54, p.139-148

2016

Volltextzugriff (PDF)

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2333-2341

2009

Volltextzugriff (PDF)

2 New targeted treatments in oncology: the mammoths and the foxes

European journal of cancer supplements, 2009, Vol.7 (2), p.3-3

Armand, J.P

2009

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of E7070, a Novel Chloroindolyl Sulfonamide Cell-Cycle Inhibitor, Administered as a One-Hour Infusion Every Three Weeks in Patients With Advanced Cancer

Journal of clinical oncology, 2002-08, Vol.20 (16), p.3508-3521

2002

Volltextzugriff (PDF)

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

European journal of cancer (1990), 1998-06, Vol.34 (7), p.1124-1127

1998

Volltextzugriff (PDF)

CPT-11 (Irinotecan) in the treatment of colorectal cancer

European journal of cancer (1990), 1995-07, Vol.31 (7), p.1283-1287

1995

Volltextzugriff (PDF)

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety

Annals of oncology, 2012-05, Vol.23 (5), p.1301-1306

2012

Volltextzugriff (PDF)

392 POSTER A phase I/II multicenter trial of BMS-690514, an ErbB-VEGFR inhibitor, in patients with advanced NSCLC who are erlotinib naive or previously treated with erlotinib

European journal of cancer supplements, 2008, Vol.6 (12), p.123-123

2008

Volltextzugriff (PDF)

176 POSTER Outcome of three Phase I trials of the marine compound ES-285 (3 hour infusion) in patients with refractory solid tumors

European journal of cancer supplements, 2008, Vol.6 (12), p.56-56

2008

Volltextzugriff (PDF)

Help your reviewer review your cancer grant

European journal of cancer (1990), 2001-04, Vol.37, p.S367-S367

Armand, J.P.

2001

Volltextzugriff (PDF)

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naive patients with glioblastoma

Annals of oncology, 2003-04, Vol.14 (4), p.603-614

2003

Volltextzugriff (PDF)

A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

European journal of cancer (1990), 2000-05, Vol.36 (8), p.1016-1025

2000

Volltextzugriff (PDF)

Non-randomised phase II trials of drug combinations: often meaningless, sometimes misleading. Are there alternative strategies?

European journal of cancer (1990), 2002-03, Vol.38 (5), p.635-638

2002

Volltextzugriff (PDF)

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers

European journal of cancer (1990), 2009, p.?-.

2009

Volltextzugriff (PDF)

Procarbazine in haematology: an old drug with a new life?

European journal of cancer (1990), 2004-09, Vol.40 (13), p.1924-1927

2004

Volltextzugriff (PDF)

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

Annals of oncology, 1998-03, Vol.9 (3), p.255-260

1998

Volltextzugriff (PDF)

Non-randomised phase II trials of drug combinations

European journal of cancer (1990), 2002-03, Vol.38 (5), p.635-638

2002

Volltextzugriff (PDF)

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

European journal of cancer (1990), 1994, Vol.30 (9), p.1263-1269

1994

Volltextzugriff (PDF)

Unusual Abdominal and Pelvic Tumors: CASE 2. SPONTANEOUS REGRESSION OF PERITONEAL IMPLANTS IN BORDERLINE OVARIAN TUMOR AFTER SALPINGO-OOPHORECTOMY

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3536-3538

2003

Volltextzugriff (PDF)

An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 1998-10, Vol.9 (10), p.1103-1107

1998

Volltextzugriff (PDF)

Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients

Annals of oncology, 2002-05, Vol.13 (5), p.760-769

2002

Volltextzugriff (PDF)

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies

Annals of oncology, 2000-01, Vol.11 (1), p.73-79

2000

Volltextzugriff (PDF)

746 The European approach to approving new anticancer medicines

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S225-S225

2003

Volltextzugriff (PDF)

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

Journal of clinical oncology, 1991-09, Vol.9 (9), p.1675-1681

1991

Volltextzugriff (PDF)

Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma

Annals of oncology, 1993-04, Vol.4 (4), p.333-336

1993

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(44)
Humans
(39)
Oncology
(32)
Female
(30)
Biological And Medical Sciences
(29)
Middle Aged
(27)
Adult
(26)
Male
(25)
Aged
(24)
Medical Sciences
(24)
Chemotherapy
(22)
Pharmacology. Drug Treatments
(21)
Antineoplastic Agents
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Adolescent
(10)
Treatment Outcome
(9)
Carcinoma, Squamous Cell - Drug Therapy
(8)
Neoplasms - Drug Therapy
(8)
Physical Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers

2 New targeted treatments in oncology: the mammoths and the foxes

Phase I and Pharmacokinetic Study of E7070, a Novel Chloroindolyl Sulfonamide Cell-Cycle Inhibitor, Administered as a One-Hour Infusion Every Three Weeks in Patients With Advanced Cancer

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

CPT-11 (Irinotecan) in the treatment of colorectal cancer

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety

392 POSTER A phase I/II multicenter trial of BMS-690514, an ErbB-VEGFR inhibitor, in patients with advanced NSCLC who are erlotinib naive or previously treated with erlotinib

176 POSTER Outcome of three Phase I trials of the marine compound ES-285 (3 hour infusion) in patients with refractory solid tumors

Help your reviewer review your cancer grant

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naive patients with glioblastoma

A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

Non-randomised phase II trials of drug combinations: often meaningless, sometimes misleading. Are there alternative strategies?

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers

Procarbazine in haematology: an old drug with a new life?

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

Non-randomised phase II trials of drug combinations

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

Unusual Abdominal and Pelvic Tumors: CASE 2. SPONTANEOUS REGRESSION OF PERITONEAL IMPLANTS IN BORDERLINE OVARIAN TUMOR AFTER SALPINGO-OOPHORECTOMY

An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies

746 The European approach to approving new anticancer medicines

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma

Suchergebnisse filtern